| Ms Amanda L Bickle, ARNP | |
|
105 W 13th, Hays, KS 67601-3082 | |
| (785) 621-4990 | |
| Not Available |
| Full Name | Ms Amanda L Bickle |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 17 Years |
| Location | 105 W 13th, Hays, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083810469 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 46045 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Ks Hlth System Great Bend Campus | Great bend, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ukhs Great Bend Llc | 5597016378 | 66 |
News Archive
Novoheart, a global stem cell biotechnology company, is pleased to announce a collaboration with global biopharmaceutical company AstraZeneca, in an effort to develop the world's first human-specific in vitro, functional model of heart failure with preserved ejection fraction (HFpEF), a common condition especially among the elderly and in women, with the reported prevalence approaching 10% in women over the age of 80 years.
As the first of the laid-off to receive a 65 percent subsidy on the cost of continuing their former employer's coverage under COBRA prepare to try to afford coverage without the subsidy, news outlets are helping people examine their options.
Nosopharm, a specialist in the research and development of new anti-infective drugs, announces today its in vitro and in vivo findings for a novel antibacterial class, Odilorhabdins, which has the potential to combat antibiotic resistance.
The bacterial cell wall that is the target of potent antibiotics such as penicillin is actually made up of a thin single layer of carbohydrate chains, linked together by peptides, which wrap around the bacterium like a belt around a person, according to research conducted by scientists at the California Institute of Technology (Caltech).
Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.
› Verified 6 days ago
| Entity Name | Ukhs Great Bend Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962997197 PECOS PAC ID: 5597016378 Enrollment ID: O20180918000770 |
News Archive
Novoheart, a global stem cell biotechnology company, is pleased to announce a collaboration with global biopharmaceutical company AstraZeneca, in an effort to develop the world's first human-specific in vitro, functional model of heart failure with preserved ejection fraction (HFpEF), a common condition especially among the elderly and in women, with the reported prevalence approaching 10% in women over the age of 80 years.
As the first of the laid-off to receive a 65 percent subsidy on the cost of continuing their former employer's coverage under COBRA prepare to try to afford coverage without the subsidy, news outlets are helping people examine their options.
Nosopharm, a specialist in the research and development of new anti-infective drugs, announces today its in vitro and in vivo findings for a novel antibacterial class, Odilorhabdins, which has the potential to combat antibiotic resistance.
The bacterial cell wall that is the target of potent antibiotics such as penicillin is actually made up of a thin single layer of carbohydrate chains, linked together by peptides, which wrap around the bacterium like a belt around a person, according to research conducted by scientists at the California Institute of Technology (Caltech).
Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Amanda L Bickle, ARNP 3306 Hillcrest Dr, Hays, KS 67601-1530 Ph: (785) 621-4990 | Ms Amanda L Bickle, ARNP 105 W 13th, Hays, KS 67601-3082 Ph: (785) 621-4990 |
News Archive
Novoheart, a global stem cell biotechnology company, is pleased to announce a collaboration with global biopharmaceutical company AstraZeneca, in an effort to develop the world's first human-specific in vitro, functional model of heart failure with preserved ejection fraction (HFpEF), a common condition especially among the elderly and in women, with the reported prevalence approaching 10% in women over the age of 80 years.
As the first of the laid-off to receive a 65 percent subsidy on the cost of continuing their former employer's coverage under COBRA prepare to try to afford coverage without the subsidy, news outlets are helping people examine their options.
Nosopharm, a specialist in the research and development of new anti-infective drugs, announces today its in vitro and in vivo findings for a novel antibacterial class, Odilorhabdins, which has the potential to combat antibiotic resistance.
The bacterial cell wall that is the target of potent antibiotics such as penicillin is actually made up of a thin single layer of carbohydrate chains, linked together by peptides, which wrap around the bacterium like a belt around a person, according to research conducted by scientists at the California Institute of Technology (Caltech).
Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.
› Verified 6 days ago
Shelley Janene Schmidt, ARNP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 207 E 7th St # B, Hays, KS 67601 Phone: 888-878-6881 Fax: 785-625-5759 | |
Dr. Steven R Waring, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2509 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5095 Fax: 785-623-5080 | |
Dr. Christopher Laurence Lundberg, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5096 Fax: 785-623-5524 | |
Dr. Jeffrey D Henry, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2509 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5095 Fax: 785-623-5080 | |
Michelle Knowles, ARNP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 207b E 7th St, Hays, KS 67601 Phone: 888-878-6881 Fax: 785-625-5759 | |
Dr. Richard L Rajewski, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2509 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5905 Fax: 785-623-5080 |